Literature DB >> 17295646

Angiogenic factors in normal endometrium and endometrial adenocarcinoma.

Mayumi Saito1, Yuichi Sato, Jun Watanabe, Hiroyuki Kuramoto, Sadayuki Kaba, Toshio Fukuda.   

Abstract

In the endometrium, angiogenesis plays important roles not only in tumor growth but also in the menstrual cycle. The purpose of the present paper was to investigate immunohistochemically the correlation between angiogenic factor expression and angiogenic score in normal and neoplastic endometrium. Immunohistochemical staining for vascular endothelial growth factor (VEGF), angiopoietin (Ang)-1, Ang2, Tie2, CD34 and CD105 was performed on formalin-fixed and paraffin-embedded tissues from 31 normal endometrium and 85 endometrial adenocarcinoma. VEGF, Ang1, Ang2 and Tie2 expression was localized in the cytoplasm of glandular and tumor cells. The levels of each angiogenic factor were different in the phases of the menstrual cycle and each layer of normal endometrium. In general, VEGF and Tie2 expression was higher in adenocarcinoma than in normal epithelial cells. Conversely, Ang1 and Ang2 expression was higher in normal epithelium than in adenocarcinoma. The angiogenic score (CD105/CD34) tended to be higher in the adenocarcinoma than in the normal epithelium. It is suggested that the angiogenic pathway and the role of these factors seem to differ between normal tissue and carcinoma of the endometrium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17295646     DOI: 10.1111/j.1440-1827.2006.02071.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  12 in total

1.  A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial.

Authors:  Kathleen N Moore; Michael W Sill; Meaghan E Tenney; Christopher J Darus; David Griffin; Theresa L Werner; Peter G Rose; Robert Behrens
Journal:  Gynecol Oncol       Date:  2015-07-11       Impact factor: 5.482

2.  Divergent regulation of angiopoietin-1 and -2, Tie-2, and thrombospondin-1 expression by estrogen in the baboon endometrium.

Authors:  Thomas W Bonagura; Graham W Aberdeen; Jeffery S Babischkin; Robert D Koos; Gerald J Pepe; Eugene D Albrecht
Journal:  Mol Reprod Dev       Date:  2010-05       Impact factor: 2.609

3.  Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage.

Authors:  Kiyoko Kato; Tomoka Takao; Ayumi Kuboyama; Yoshihiro Tanaka; Tatsuhiro Ohgami; Shinichiro Yamaguchi; Sawako Adachi; Tomoko Yoneda; Yousuke Ueoka; Keiji Kato; Shinichi Hayashi; Kazuo Asanoma; Norio Wake
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

4.  The pattern of expression of Notch protein members in normal and pathological endometrium.

Authors:  Luigi Cobellis; Francesca Caprio; Elisabetta Trabucco; Annunziata Mastrogiacomo; Gabriele Coppola; Lucrezia Manente; Nicola Colacurci; Maria De Falco; Antonio De Luca
Journal:  J Anat       Date:  2008-08-04       Impact factor: 2.610

5.  Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N.

Authors:  Vicky Makker; Virginia L Filiaci; Lee-May Chen; Christopher J Darus; James E Kendrick; Gregory Sutton; Katherine Moxley; Carol Aghajanian
Journal:  Gynecol Oncol       Date:  2015-04-16       Impact factor: 5.482

6.  The Potential Roles of MELF-Pattern, Microvessel Density, and VEGF Expression in Survival of Patients with Endometrioid Endometrial Carcinoma: A Morphometrical and Immunohistochemical Analysis of 100 Cases.

Authors:  Dmitry Aleksandrovich Zinovkin; Md Zahidul Islam Pranjol; Daniil Rudolfovich Petrenyov; Eldar Arkadievich Nadyrov; Oleg Gennadievich Savchenko
Journal:  J Pathol Transl Med       Date:  2017-09-14

7.  The Expression of VEGF and CD31 in Endometrial Lesions and Its Associations with Blood Flow Parameters of Transvaginal 3D Power Doppler Ultrasonography: A Preliminary Study.

Authors:  Meijuan Liu; Li Cai; Qifan Li; Xiaoran Chen; Lingyun Gao; Lei Jiang
Journal:  Cancer Manag Res       Date:  2020-11-04       Impact factor: 3.989

Review 8.  The Influence of Biologically Active Substances Secreted by the Adipose Tissue on Endometrial Cancer.

Authors:  Kaja Michalczyk; Natalia Niklas; Małgorzata Rychlicka; Aneta Cymbaluk-Płoska
Journal:  Diagnostics (Basel)       Date:  2021-03-11

Review 9.  The role of angiogenic factors in endometrial cancer.

Authors:  Monika Magdalena Żyła; Marta Kostrzewa; Ewelina Litwińska; Artur Szpakowski; Jacek Radosław Wilczyński; Tomasz Stetkiewicz
Journal:  Prz Menopauzalny       Date:  2014-05-21

10.  Clinical value of selected markers of angiogenesis, inflammation, insulin resistance and obesity in type 1 endometrial cancer.

Authors:  Katarzyna M Terlikowska; Bozena Dobrzycka; Robert Terlikowski; Anna Sienkiewicz; Maciej Kinalski; Slawomir J Terlikowski
Journal:  BMC Cancer       Date:  2020-09-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.